Ron Alterman Selected Research

Ron Alterman Research Topics

10	Parkinson Disease (Parkinson's Disease) 01/2021 - 06/2010
2	Dystonia (Limb Dystonia) 01/2017 - 09/2004
1	Ocular Motility Disorders (Convergence Insufficiency) 01/2021
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2021
1	Parkinsonian Disorders (Parkinsonism) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 01/2021
1	Fatigue 01/2021
1	Neuroacanthocytosis 05/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2019
1	Hyperkinesis 05/2019
1	Mental Disorders (Mental Disorder) 01/2017
1	Abscess 04/2016
1	Hemorrhage 04/2016
1	Tremor (Tremors) 01/2015
1	Movement Disorders (Movement Disorder) 09/2013
1	Essential Tremor (Essential Tremors) 06/2010
1	Mood Disorders (Mood Disorder) 05/2008
1	Major Depressive Disorder (Major Depressive Disorders) 05/2008
1	Treatment-Resistant Depressive Disorder 05/2008
1	Dystonic Disorders (Writer's Cramp) 09/2004

2	NeurturinIBA 08/2015 - 12/2010
2	salicylhydroxamic acid (SHAM)IBA 08/2015 - 12/2010
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	Dopamine Agents (Dopaminergic Agents)IBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	Gemcitabine FDA Link 01/2021
1	Ifosfamide FDA LinkGeneric 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Fetal Proteins (Fetoprotein)IBA 01/2021
1	Pharmaceutical PreparationsIBA 05/2019
1	Proteins (Proteins, Gene)FDA Link 05/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2016
1	Nerve Growth Factors (Neurotrophins)IBA 04/2013
1	Botulinum Toxins (Botulinum Toxin)IBA 09/2004

11	Deep Brain Stimulation 01/2021 - 09/2004
4	Therapeutics 01/2018 - 05/2008
2	Electrodes (Electrode) 01/2017 - 09/2013
1	Induction Chemotherapy 01/2021
1	Treatment Delay 04/2016
1	Cochlear Implants (Cochlear Implant) 06/2010
1	Transcranial Direct Current Stimulation 05/2008
1	Drug Therapy (Chemotherapy) 05/2008
1	Transcranial Magnetic Stimulation 05/2008
1	Vagus Nerve Stimulation 05/2008
1	Injections 09/2004